APL Apollo Tubes Q4 PAT may increase 72.2% YoY to Rs 98 cr: Sharekhan
Wed, Apr 14, 2021 6:55 PM

APL Apollo Tubes Q4 PAT may increase 72.2% YoY to Rs 98 cr: Sharekhan

A Flip by Flipitnews
Get it on Google Play
Sharekhan has worked out its Q4 (January-March’ 21) earnings estimates for the Building Materials sector. The brokerage house expects APL Apollo Tubes to report net profit at Rs 98 crore up 72.2% year-on-year (down 25.9% quarter-on-quarter). Net Sales are expected to increase by 26.7% Y-o-Y (down 8% Q-o-Q) to Rs 2,393 crore, according to Sharekhan.

More great flips

Bulk deals: Polunin Emerging Markets Small Cap Fund sells stake in Chennai

Bulk deals: Polunin Emerging Markets Small Cap Fund sells stake in Chennai

In Chennai Petroleum Corporation, foreign investor Polunin Emerging Markets Small Cap Fund LLC sold 7.87 lakh shares, or a 0.52 percent stake, at an average price of Rs 887.16. Polunin Emerging Markets Small Cap Fund LLC held a 1.12 percent stake in the company til March 2024.Indian Oil Corporation holds the highest stake in Chennai Petroleum Corporation, as they have 51.89 percent stake.

Open Flip
Gujarat State Petronet quarterly net profit rises 22%, announces dividend

Gujarat State Petronet quarterly net profit rises 22%, announces dividend

Gujarat State Petronet Ltd (GSPL) on Wednesday (May 8) reported a 22.2% year-on-year (YoY) increase in net profit at ₹663.1 crore for the fourth quarter that ended March 31, 2024. In the corresponding quarter, Gujarat State Petronet posted a net profit of ₹542.8 crore, the company said in a regulatory filing. The company's revenue from operations increased 5.9% to ₹4,522.2 crore against ₹4,270.

Open Flip
After AstraZeneca covid-19 vax recall worldwide!

After AstraZeneca covid-19 vax recall worldwide!

New Delhi: The Serum Institute of India (SII) on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide.Both companies cited lack of demand for their move. The vaccine used in Europe is called Vaxzervia.

Open Flip

Join our Smart Investment Community

More than 1 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon